Stocks Comparison
Medpace vs OmniAb: revenue, profit, margins and growth compared
Medpace brought in $2.5B of revenue in fiscal 2025, OmniAb $18.7M in fiscal 2025. Revenue changed by +20.0% at Medpace and -29.3% at OmniAb on the year before, so Medpace grew faster. Medpace kept 17.8% of its revenue as net profit, OmniAb -347.0%. Free cash flow was $681.9M at Medpace and -$37M at OmniAb.
Side by side, latest fiscal year
| MEDP | OABI | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $2.5B | $18.7M |
| Revenue growth | +20.0% | -29.3% |
| Net income | $451.1M | -$64.8M |
| Net margin | 17.8% | -347.0% |
| Free cash flow | $681.9M | -$37M |
| Free cash flow margin | 26.9% | -198.3% |
| Earnings per share (diluted) | $15.28 | -$0.57 |
| Cash | $497M | $25.5M |
| Debt | n/a | n/a |
| Price to earnings | 40.5 | n/a |
| Market value | $17.3B | $670.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #94 of 523 · Health care | #413 of 523 · Health care |
Over the years
Questions about Medpace and OmniAb
Which is bigger by revenue, Medpace or OmniAb?
Medpace is bigger by revenue: $2.5B in fiscal 2025, against $18.7M for OmniAb in fiscal 2025.
Which keeps more of its revenue as profit, Medpace or OmniAb?
Medpace had a net margin of 17.8% in fiscal 2025; OmniAb had -347.0% in fiscal 2025.
Which grew revenue faster, Medpace or OmniAb?
In their latest fiscal years revenue changed by +20.0% at Medpace and -29.3% at OmniAb.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.